In the News

48753 ksm logo_biz3_1.png

Published today in Doctorsonly

Linkedin

June 13, 2021

48753 ksm logo_biz3_1.png

KSM study in the New York Times!
Our academia-healthcare collaboration with Technion Institute of Technology appearing in the New York Times.
The study "Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals" just published.

New York Times

June 11, 2021

48753 ksm logo_biz3_1.png

Our joint research with Prof. Roy Kishony and his team from Technion Institute "Community-level evidence for Coronavirus vaccine protection of unvaccinated individuals" published today on Nature Medicine Magazine.

Nature Medicine Magazine

June 10, 2021

48753 ksm logo_biz3_1.png

A new research by KSM shows most respondents are in favor of vaccinating 12-16 year olds— men more in favor than women. Furthermore, new insights on additional vaccine doses, mask usage stats and more are described.

Doctors Only ( In Hebrew).

June 6, 2021

48753 ksm logo_biz3_1.png

New KSM research in association with IBM:
Trends in clinical characteristics of severe non-respiratory events related to Coronavirus patients

Linkedin

Apr 18, 2021

48753 ksm logo_biz3_1.png

Our new survey on behaviour attitudes towards preventive measures following Coronavirus vaccination

Linkedin

Apr 14, 2021

48753 ksm logo_biz3_1.png

A new KSM study shows that the rate of children diagnosed with celiac disease in Israel has increased almost threefold over a decade

Ynet (In Hebrew)

Mar 25, 2021

48753 ksm logo_biz3_1.png

Continuing to monitor vaccinated members - 62 days following the first vaccine dose

Linkedin

Mar 11, 2021

48753 ksm logo_biz3_1.png

Our new study on Coronavirus reinfection published today on DoctorsOnly

Doctors Only (In Hebrew)

Mar 10, 2021

48753 ksm logo_biz3_1.png

KSM is publishing a new real world data study on reinfected Maccabi members

Linkedin

Mar 09, 2021

48753 ksm logo_biz3_1.png

A retrospective analysis of serological data in 116 Israeli healthcare workers administered with the Coronavirus vaccine

Linkedin

Mar 07, 2021

48753 ksm logo_biz3_1.png

Continuing to monitor vaccinated members. Coronavirus update February 18

Linkedin

Feb 18, 2021

48753 ksm logo_biz3_1.png


KSM is calling for research proposals

Linkedin (In Hebrew)

Feb 16, 2021

48753 ksm logo_biz3_1.png


We're hiring data scientists

Linkedin

Feb 11, 2021

48753 ksm logo_biz3_1.png


Continuing to monitor vaccinated members at Maccabi

Linkedin

Feb 10, 2021

48753 ksm logo_biz3_1.png

continuing to monitor vaccinated members at Maccabi

Linkedin

Feb 01, 2021

48753 ksm logo_biz3_1.png

New analysis 28 days after the first vaccination dose

Linkedin

Feb 01, 2021

48753 ksm logo_biz3_1.png

KSM publishes world’s first scientific article on effectiveness of Coronavirus vaccine 13-24 days after 1st dose: real world evidence

LinkedIn

Jan 31, 2021

48753 ksm logo_biz3_1.png

KSM - Maccabi Research and Innovation Center - publishes insights from real-time monitoring of Corona virus vaccination data.

LinkedIn

Jan 22, 2021

48753 ksm logo_biz3_1.png


COVID-19: World's first analysis of vaccine data by KSM

Channel 12 News (In Hebrew)

Jan 12, 2021